
Pharmaceutical firm Gilead Sciences has just put up a cool $11.9 billion to acquire Kite Pharma, which has developed a genetic engineering approach for treating cancers.

Pharmaceutical firm Gilead Sciences has just put up a cool $11.9 billion to acquire Kite Pharma, which has developed a genetic engineering approach for treating cancers.

Every year, as part of their strategic planning, executives’ minds turn to setting performance targets—and then achieving them. In so doing, those at medical-device companies should bear in mind the high hopes shareholders have for future growth. Can these hopes be met?

On Monday, the California gene-hunting company Human Longevity published a paper making the bold claim that it can identify individuals using their genomes to predict what their faces looks like.

Scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) in San Diego, California have devised a way to optically image tumors with unprecedented clarity using quantum dots. These nano structures are tiny particles, only a few nanometers wide, that generate light of a specific wavelength when they’re themselves stimulated by a light beam. On their own quantum dots are quite bright, but their signal gets washed out by other nearby quantum dots. To clean the signal and be able to see tumors better, the SBP team used a so-called “etchant”.

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) is pleased to announce the 12 finalists selected to pitch their pediatric medical device innovation at our 5th Annual Pediatric Device Innovation Symposium on Sunday, September 24th in San Jose, CA.

Can genomics wizards make an informed guesstimate on what a person looks like, based on his or her DNA? J. Craig Venter sure thinks so, per a new PNAS paper. Yet his Human Longevity Institute study is facing Twitter blowback for that claim.

BioHealth Innovation CEO, Richard Bendis discusses with Montgomery County Economic Development Corporation for #MOCO365 how BioHealth Innovation helps accelerate the growth of life science and biohealth companies.

Inova announced today that Mickey Y. Kim, MD, MBA, has been named Senior Vice President of Research and Commercialization. In this role, Dr. Kim will work with Inova’s institute leaders to establish Inova’s research priorities, manage its portfolio, work collaboratively with Inova’s external partners, and drive the commercialization of research.

Do you have experience in digital health? Are you passionate about developing innovative solutions to complex challenges? If so, consider joining the FDA Digital Health team as an Entrepreneur-in-Residence! The Center for Devices and Radiological Health (CDRH) is establishing this Entrepreneur-in-Residence (EIR) Program to support and help develop our Software Precertification (PreCert) Pilot Program —a critical piece of our Digital Health Innovation Action Plan, announced on August 8, 2017.

DATE AND TIME: Wed, September 27, 2017 8:00 AM – 10:00 AM EDT
LOCATION: 1801 Rockville Pike Suite 320 Rockville, MD 20852
Join us for our open house to connect and network in our new Rockville offices. Enjoy breakfast and discover the many services we offer to help expand business opportunities in MoCo.
We hope you can join us.
Garage parking is available in the building. If you have any questions, please contact Meaghann Diez at meaghann@thinkmoco.com.